StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Amphastar Pharmaceuticals (AMPH) PT Raised to $23 at BMO Capital
March 13, 2019 6:36 AM
BMO Capital analyst Gary Nachman raised the price target on Amphastar Pharmaceuticals (NASDAQ: AMPH) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS View
Analyst PT Change
Next Articles
Piper Jaffray Downgrades Amphastar Pharmaceuticals (AMPH) to Neutral
March 13, 2019 2:36 AM
Amphastar Pharmaceuticals (AMPH) PT Raised to $28 at Jefferies
March 13, 2019 2:26 AM
After-Hours Movers 03/12: (CLNE) (TEUM) (NTRA) Higher; (PEIX) (VSTM) (LMNR) (more...)
March 12, 2019 5:44 PM
Form 8-K Amphastar Pharmaceutical For: Mar 12
March 12, 2019 4:21 PM
Amphastar Pharma (AMPH) Tops Q4 EPS by 2c
March 12, 2019 4:17 PM
